Omega Therapeutics, Inc. (OMGAQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0330
+0.0010 (3.12%)
May 30, 2025, 4:00 PM EDT
Omega Therapeutics Market Cap
Omega Therapeutics has a market cap or net worth of $1.83 million as of May 30, 2025. Its market cap has decreased by -98.60% in one year.
Market Cap
1.83M
Enterprise Value
99.58M
Revenue
8.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since July 30, 2021, Omega Therapeutics's market cap has decreased from 747.61M to 1.83M, a decrease of -99.76%. That is a compound annual growth rate of -79.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 1.83M | -95.57% |
| Dec 31, 2024 | 41.28M | -75.13% |
| Dec 29, 2023 | 165.98M | -39.50% |
| Dec 30, 2022 | 274.36M | -49.31% |
| Dec 31, 2021 | 541.29M | -27.60% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.62B |
| Veradigm | 721.76M |
| Nika Pharmaceuticals | 667.04M |
| Tian'an Technology Group | 614.49M |
| Elite Pharmaceuticals | 574.52M |
| Glass House Brands | 452.21M |
| CytoDyn | 421.23M |
| Northwest Biotherapeutics | 386.43M |